Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of van Beek headgear activator in adolescents with UARS and hyperdivergent skeletal class II malocclusion: dentofacial morphology, airway, and growth.

BMC oral health·2026
Same author

Big Endothelin-1 Predicts the long-term survival in patients undergoing septal myectomy.

International journal of cardiology. Heart & vasculature·2026
Same author

Image Quality and Diagnostic Accuracy of Third-Generation Dual-Source CT With High-Pitch Scanning for Coronary CTA in Patients With Atrial Fibrillation and Breath-Holding Inability.

Journal of computer assisted tomography·2026
Same author

Biwt-UNet: lung nodule segmentation via wavelet transform and multi-scale feature fusion.

Biomedical physics & engineering express·2026
Same author

Proteomic profiling identifies molecular subtypes and unveils mechanistic insights into clinical features of hypertrophic cardiomyopathy.

Journal of translational medicine·2026
Same author

The Basic Helix-Loop-Helix Transcription Factors UvBhlh1 and UvBhlh6 Coordinate Virulence in the Rice False Smut Fungus Ustilaginoidea virens.

Molecular plant pathology·2026

Related Experiment Video

Updated: May 27, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Estimation of treatment effect for the sequential parallel design.

Roy N Tamura1, Xiaohong Huang, Dennis D Boos

  • 1Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. tamura_roy_n@lilly.com

Statistics in Medicine
|December 6, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces improved methods for estimating treatment effects in sequential parallel clinical trials, enhancing precision by utilizing data from both trial phases. These advancements are particularly beneficial for psychiatric studies with high placebo response rates.

Related Experiment Videos

Last Updated: May 27, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Clinical trial design
  • Psychiatric research methodology
  • Biostatistics

Background:

  • Sequential parallel clinical trial designs are used for psychiatric diseases with high placebo response rates.
  • This design involves an initial parallel trial followed by a second trial in placebo non-responders.
  • Existing statistical research primarily focuses on hypothesis testing within this design.

Purpose of the Study:

  • To develop methods for estimating treatment effects that incorporate data from both phases of a sequential parallel trial.
  • To improve the precision of treatment effect estimates in sequential parallel trials.
  • To address the limitation of ignoring valuable data from the second trial phase.

Main Methods:

  • Development of novel statistical estimators for treatment effect.
  • Incorporation of data from both the initial and second phases of the sequential parallel trial.
  • Simulation studies and analysis of a real-world clinical trial dataset.

Main Results:

  • The proposed methods provide more precise estimates of the overall treatment effect by using data from both trial phases.
  • Substantial gains in precision were observed through simulations and a real data example.
  • The benefits of incorporating both phases appear most significant in moderate-sized trials, such as those in Phase II.

Conclusions:

  • Estimating treatment effects using data from both phases of a sequential parallel trial enhances precision.
  • This approach offers significant advantages over methods that only consider the first phase.
  • The refined estimation methods are valuable for psychiatric clinical trials and Phase II drug development.